Pharmacological Venous Thromboembolism Prophylaxis in Meningioma Patients: Should it be Earlier than in Clinical Practice?

References (1)

1. Celtikci E, Kaymaz AM, Akgul G, Karaaslan B, Emmez OH, Borcek A: Retrospective analysis of 449 intracranial meningioma patients operated between years 2007 – 2013 in a single institute. Turk Neurosurg 28(1): 1-6,2018 2. Eisenring CV, Neidert MC, Sabanés Bové D, Held L, Sarnthein J, Krayenbühl N: Reduction of thromboembolic events in meningioma surgery: A cohort study of 724 consecutive patients. PLoS One 8(11):e79170, 2013 3. Gerlach R, Krause M, Seifert V, Goerlinger K: Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir 151: 873–900, 2009 4. Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, Haupt WF, Schön R: Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien) 145(12):1085-1090, 2003 5. Zacharia BE, Youngerman BE, Bruce SS, Hershman DL, Neugut AI, Bruce JN, Wright JD: Quality of postoperative venous thromboembolism prophylaxis in neuro-oncologic surgery. Neurosurgery 80(1):73-81,2017